TRAQ, founded in 2016 and headquartered in the United States, is carving out a unique space in the intersection of Biotechnology, Consumer Electronics, and Health Care. The company focuses on utilizing saliva for Fitness, Health & Wellness Tracking, thus providing a non-invasive approach to real-time biomarker analysis.
TRAQ's device empowers users to "Own Your Health" by delivering immediate insights into general wellness and athletic performance. It supports users with personalized recommendations, encouraging healthy lifestyles by leveraging the company's expertise in Life Sciences and Information Technology. The broader target market spans from everyday individuals to dedicated athletes.
After a successful $4.50M Series A investment on 01 November 2021, TRAQ is poised for growth. The capital is likely earmarked for scaling technology capabilities and market penetration, though further investor information remains undisclosed. This investment positions TRAQ as a promising candidate for future investment rounds as it continues to innovate in the sports and health tech sectors.